focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,753.00
Ask: 1,754.00
Change: -19.00 (-1.07%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATING CHANGES: Goldman Cuts RBS To Neutral From Buy

Tue, 12th Nov 2013 10:18

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Monday afternoon:
----------
FTSE 100
----------
NOMURA DOWNGRADES BRITISH SKY BROADCASTING GROUP PLC (BSY.L) TO REDUCE FROM BUY
----------
S&P CAPITAL IQ CUTS BSKYB TO 'SELL' ('BUY') - PRICE TARGET 700 (1050) PENCE
----------
CREDIT SUISSE CUTS BSKYB TO 'UNDERPERFORM' ('NEUTRAL') - PRICE TARGET 700 (810) PENCE
----------
UBS RAISES SMITHS GROUP PRICE TARGET TO 1000 (750) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RBS TO 'NEUTRAL' ('BUY') - TARGET 370 (400) PENCE
----------
NOMURA RAISES RBS PRICE TARGET TO 285 (270) PENCE - 'REDUCE'
----------
MACQUARIE REMOVES RBS FROM 'CONVICTION SELL LIST'
----------
JPMORGAN CUTS RSA INSURANCE TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 126 (140) P.
----------
NOMURA CUTS RSA INSURANCE PRICE TARGET TO 113 (120) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS ITV TO 'NEUTRAL' ('BUY') - TARGET 191 (180) PENCE
----------
PANMURE CUTS GLAXOSMITHKLINE TO 'HOLD' ('BUY') - TARGET 1,750 (1,850) PENCE
----------
SOCGEN RAISES SHIRE PRICE TARGET TO 3615 (3270) PENCE - 'BUY'
----------
MACQUARIE REMOVES IAG FROM 'CONVICTION BUY LIST' - 'OUTPERFORM'
----------
MORGAN STANLEY RAISES ROLLS-ROYCE PRICE TARGET TO 1400 (1300) P. - 'OVERWEIGHT'
----------
FTSE 250
----------
UBS CUTS BALFOUR BEATTY TO 'SELL' ('NEUTRAL') - TARGET 245 (220) PENCE
----------
UBS CUTS COBHAM PRICE TARGET TO 290 (305) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS COBHAM PRICE TARGET TO 270 (275) PENCE - 'HOLD'
----------
BARCLAYS INITIATES F&C ASSET MANAGEMENT WITH 'UNDERWEIGHT' - TARGET 90 PENCE
----------
CITIGROUP RAISES LONMIN PRICE TARGET TO 453 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES LONMIN PRICE TARGET TO 390 (315) PENCE - 'HOLD'
----------
JPMORGAN RAISES LONMIN PRICE TARGET TO 430 (400) PENCE - 'OVERWEIGHT'
----------
HSBC RAISES LONMIN PRICE TARGET TO 512 (485) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK RAISES HALFORDS GROUP PRICE TARGET TO 410 (330) PENCE - 'SELL'
----------
DEUTSCHE BANK RAISES WH SMITH PLC PRICE TARGET TO 1075 (960) PENCE - 'BUY'
----------
EXANE BNP RAISES SHAFTESBURY TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 580 PENCE
----------
NUMIS CUTS MENZIES(JOHN) TO 'HOLD' ('ADD') - TARGET 774 (834) PENCE
----------
PANMURE RAISES BTG PRICE TARGET TO 490 (450) PENCE - 'BUY'
----------
PANMURE RAISES RIGHTMOVE PRICE TARGET TO 3,130 (3,000) PENCE - 'BUY'
----------
CANACCORD RAISES CATLIN GROUP PRICE TARGET TO 550 (540) PENCE - 'BUY'
----------
NUMIS RAISES CATLIN GROUP TO 'HOLD' ('REDUCE') - TARGET 575 (420) PENCE
----------
JEFFERIES CUTS MORGAN ADVANCED MATERIALS PRICE TARGET TO 340 (345) PENCE- 'BUY'
----------
JEFFERIES RAISES RENTOKIL INITIAL PRICE TARGET TO 116 (104) PENCE - 'HOLD'
----------
NUMIS CUTS DIGNITY TO 'HOLD' ('ADD') - TARGET 1,575 (1,625) PENCE
----------
Numis Upgrades Oxford Instruments To Buy From Add, Price Target 1,600p
----------
ALL-SHARE AND AIM
----------
GOLDMAN RAISES SHANKS GROUP PRICE TARGET TO 128 (126) PENCE - 'BUY'
----------
CANACCORD CUTS CHESNARA PLC TO 'HOLD' ('BUY') - TARGET 300 (290) PENCE
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.